Immunopathological changes in a uraemic rat model for peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 20, Issue 7, 2005, Pages 1350-1361

  Zareie, Mohammad ^a   De Vriese, An S ^b   Hekking, Liesbeth H P ^a   ter Wee, Piet M ^a   Schalkwijk, Casper G ^a   Driesprong, Bas A J ^a   Schadee Eestermans, Inge L ^a   Beelen, Robert H J ^a   Lameire, Norbert ^b   van den Born, Jacob ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

AGE; Angiogenesis; Fibrosis; Peritoneal Dialysis; Rat; Uraemia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOGENIC FACTOR; CREATININE; GLUCOSE; HYALURONIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; PERITONEAL DIALYSIS FLUID; UREA; VASCULOTROPIN; AUTACOID; DIALYSIS FLUID;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FIBROSIS; GRANULATION TISSUE; HEMATOCRIT; IMMUNOPATHOLOGY; IMMUNOSTIMULATION; KIDNEY FAILURE; LONG TERM CARE; MALE; MESOTHELIUM CELL; NEPHRECTOMY; NONHUMAN; OMENTUM; PERITONEAL DIALYSIS; PERITONEUM; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION; UREA BLOOD LEVEL; UREMIA; ANIMAL; DISEASE MODEL; DRUG EFFECT; EPITHELIUM; IMMUNOLOGY; LEUKOCYTE; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; DIALYSIS SOLUTIONS; DISEASE MODELS, ANIMAL; EPITHELIUM; GLYCOSYLATION END PRODUCTS, ADVANCED; INFLAMMATION MEDIATORS; LEUKOCYTES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NEPHRECTOMY; PERITONEAL DIALYSIS; PERITONEUM; RATS; RATS, WISTAR; UREMIA;

EID: 26044476635     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh835     Document Type: Article

References (26)

1. Williams JD, Craig KJ, Topley N et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470-479
2. Hendriks PM, Ho-dac-Pannekeet MM, van Gulik TM. Peritoneal sclerosis in chronic peritoneal dialysis patients: Analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int 1997; 17: 136-143
3. Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol 2002; 13: 480-489
4. Hekking LH, Zareie M, Driesprong BA et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol 2001; 12: 2775-2786
5. Linden T, Musi B, Jarkelid L et al. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells. Perit Dial Int 2001; 21: 607-610
6. Combet S, Ferrier ML, Van Landschoot M et al. Chronic uraemia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. J Am Soc Nephrol 2001; 12: 2146-2157
7. Muchaneta-Kubara EC, Sayed-Ahmed N, El Nahas AM. Subtotal nephrectomy: A mosaic of growth factors. Nephrol Dial Transplant 1995; 10: 320-327
8. Amann K, Kronenberg G, Gehlen F et al. Cardiac remodeling in experimental renal failure: An immunohistochemical study. Nephrol Dial Transplant 1998; 13: 1958-1966
9. Lameire N, Van Biesen W, Van Landschoot M et al. Experimental models in peritoneal dialysis: A European experience. Kidney Int 1998; 54: 2194-2206
10. De Vriese AS, Mortier S, Cornelissen M et al. The effects of heparin administration in an animal model of chronic dialysate exposure. Perit Dial Int 2002; 22: 566-572
11. Zareie M, Hekking LHP, Welten AGA et al. Contribution of lactate buffer, glucose and glucose degradation end products to peritoneal injury in vivo. Nephrol Dial Transplant 2003; 18: 2629-2637
12. Doherty NS, Griffiths RJ, Hakkinen JP. Post-capillary venules in the milky spots of the greater omentum are the major side of plasma protein and leukocyte extravasation in rodent models of peritonitis. Inflamm Res 1995; 44: 169-177
13. Beelen RHJ, Fluitsma DM, Hoefsmit ECM. The cellular composition of omentum milky spots and the ultrastructure of milky spot macrophages and retriculum cells. J Retriculoenendothel Soc 1980; 28: 585-599
14. Mortier S, Faict D, Schalkwijk C et al. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 2004; 66: 1257-1265
15. Fosang AJ, Hey NJ, Carney SL, Hardingham TE. An ELISA plate-based assay for hyaluronan using biotinylated proteoglycan G1 domain (HA-binding region). Matrix 1990; 10: 306-313
16. Jacobson SH, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002; 22: 42-47
17. Miyata T, Horie K, Ueda Y et al. Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000;58: 425-435
18. Blair RJ, Meng H, Marchese MJ et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700
19. Qu Z, Liebler JM, Powers MR et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147: 564-573
20. Zweers MM, Struijk DG, Smith W, Krediet RT. Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow-up. J Lab Clin Med 2001; 137: 125-132
21. De Vriese AS, Tilton RG, Stephan CC, Lameire N. Diabetes-induced microvascular proliferation and hyperpermeability in the peritoneum: role of vascular endothelial growth factor. J Am Soc Nephrol 2001; 12: 1734-1741
22. Zareie M, Lambalgen AA, De Vriese AS et al. Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis. Peri Dial Int 2002; 22: 655-662
23. Lee SK, Kim BS, Yang WS, Kim SB, Park SK, Park JS. High glucose induces MCP-1 expression partly via tyrosine kinase-AP-1 pathway in peritoneal mesothelial cells. Kidney Int 2001; 60: 55-64
24. Salcedo R, Ponce ML, Young HA et al. Human endothelial cells express CCR2 and respond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000; 96: 34-40
25. Slavin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002; 277: 41046-41059
26. Simpson MA, Wilson CM, McCarthy JB. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol 2002; 161: 849-885